Investing.com - Rapid Micro Biosystems (NASDAQ: RPID) reported third quarter EPS of $-0.31, in line with the analyst estimate of $-0.31. Revenue for the quarter came in at $6.1M versus the consensus estimate of $5.55M.
Guidance
Rapid Micro Biosystems sees FY 2023 revenue of $22.00M versus the analyst consensus of $22.26M.
Rapid Micro Biosystems's stock price closed at $1.01. It is up 9.78% in the last 3 months and down -59.60% in the last 12 months.
Rapid Micro Biosystems saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Rapid Micro Biosystems's stock price’s past reactions to earnings here.
According to InvestingPro, Rapid Micro Biosystems's Financial Health score is "fair performance".
Check out Rapid Micro Biosystems's recent earnings performance, and Rapid Micro Biosystems's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar